Home Subjects Licensing

Licensing

Ranbaxy enters into licensing pact with EPIRUS Switzerland

New Delhi January 10, 2014: Ranbaxy Laboratories on Thursday inked a licensing pact with EPIRUS Switzerland GmbH for BOW015, a biosimilar version of Infliximab prescribed to treat rheumatoid arthritis (RA).EPIRUS Switzerland GmbH is a wholly-owned subsidiary of Boston-based Epirus...

Biocon inks licensing pact with US-based Quark Pharma

New Delhi December 20, 2013: Biotechnology major Biocon today said it has inked a pact with Quark Pharmaceuticals, Inc to develop a range of siRNA (small interfering RNA) based novel therapeutics. The companies have entered into a licensing and collaboration agreement...